Advertisement

Macular Telangiectasia

  • Peter Charbel Issa
  • Simone Müller
  • Tjebo F. C. Heeren
  • Frank G. Holz
Chapter

Abstract

This chapter contains excerpts, reprinted from Charbel Issa et al. (2013) with permission from Elsevier.

Keywords

Optical Coherence Tomography Well Correct Visual Acuity Macular Hole Diabetic Macular Edema Choroidal Thickness 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Barthelmes D, Gillies MC, Sutter FKP (2008) Quantitative OCT analysis of idiopathic perifoveal telangiectasia. Invest Ophthalmol Vis Sci 49:2156–2162. doi: 10.1167/iovs.07-0478 CrossRefPubMedGoogle Scholar
  2. Charbel Issa P, Helb H-M, Rohrschneider K, Holz FG, Scholl HPN (2007) Microperimetric assessment of patients with type 2 idiopathic macular telangiectasia. Invest Ophthalmol Vis Sci 48:3788–3795. doi: 10.1167/iovs.06-1272 CrossRefPubMedGoogle Scholar
  3. Charbel Issa P, Helb H-M, Holz FG, Scholl HPN, MacTel Study Group (2008a) Correlation of macular function with retinal thickness in nonproliferative type 2 idiopathic macular telangiectasia. Am J Ophthalmol 145:169–175. doi: 10.1016/j.ajo.2007.08.028 CrossRefPubMedGoogle Scholar
  4. Charbel Issa P, Finger RP, Holz FG, Scholl HPN (2008b) Eighteen-month follow-up of intravitreal bevacizumab in type 2 idiopathic macular telangiectasia. Br J Ophthalmol 92:941–945. doi: 10.1136/bjo.2007.129627 CrossRefPubMedGoogle Scholar
  5. Charbel Issa P, Berendschot TT, Staurenghi G, Holz FG, Scholl HPN (2008c) Confocal blue reflectance imaging in type 2 idiopathic macular telangiectasia. Invest Ophthalmol Vis Sci 49:1172–1177. doi: 10.1167/iovs.07-0636 CrossRefPubMedGoogle Scholar
  6. Charbel Issa P, Holz FG, Scholl HPN (2009a) Metamorphopsia in patients with macular telangiectasia type 2. Doc Ophthalmol 119:133–140. doi: 10.1007/s10633-009-9190-9 CrossRefPubMedGoogle Scholar
  7. Charbel Issa P, van der Veen RLP, Stijfs A, Holz FG, Scholl HPN, Berendschot TT (2009b) Quantification of reduced macular pigment optical density in the central retina in macular telangiectasia type 2. Exp Eye Res 89:25–31. doi: 10.1016/j.exer.2009.02.006 CrossRefPubMedGoogle Scholar
  8. Charbel Issa P, Troeger E, Finger R, Holz FG, Wilke R, Scholl HPN (2010) Structure-function correlation of the human central retina. PLoS One 5:e12864. doi: 10.1371/journal.pone.0012864 CrossRefPubMedPubMedCentralGoogle Scholar
  9. Clemons TE, Gillies MC, Chew EY, Bird AC, Peto T, Figueroa MJ, Harrington MW, MacTel Research Group (2010) Baseline characteristics of participants in the natural history study of macular telangiectasia (MacTel) MacTel Project Report No. 2. Ophthalmic Epidemiol 17:66–73. doi: 10.3109/09286580903450361 CrossRefPubMedGoogle Scholar
  10. Charbel Issa P, Gillies MC, Chew EY, Bird AC, Heeren T, Peto T, Holz FG, Scholl HPN (2013) Macular telangiectasia type 2. Prog Retin Eye Res 34:49–77. doi: 10.1016/j.preteyeres.2012.11.002 CrossRefPubMedGoogle Scholar
  11. Charbel Issa P, Heeren TF, Kupitz EH, Holz FG, Berendschot TT (2016) Very early disease manifestations of macular telangiectasia type 2. Retina 36:524–534. doi: 10.1097/IAE.0000000000000863
  12. Cherepanoff S, Killingsworth MC, Zhu M, Nolan T, Hunyor AP, Young SH, Hageman GS, Gillies MC (2012) Ultrastructural and clinical evidence of subretinal debris accumulation in type 2 macular telangiectasia. Br J Ophthalmol 96:1404–1409. doi: 10.1136/bjophthalmol-2011-301009 CrossRefPubMedPubMedCentralGoogle Scholar
  13. Chhablani J, Kozak I, Jonnadula GB, Venkata A, Narayanan R, Pappuru RR, Rao PS (2014) Choroidal thickness in macular telangiectasia type 2. Retina 34:1819–1823. doi: 10.1097/IAE.0000000000000180 CrossRefPubMedGoogle Scholar
  14. Finger RP, Charbel Issa P, Fimmers R, Holz FG, Rubin GS, Scholl HPN (2009) Reading performance is reduced by parafoveal scotomas in patients with macular telangiectasia type 2. Invest Ophthalmol Vis Sci 50:1366–1370. doi: 10.1167/iovs.08-2032 CrossRefPubMedGoogle Scholar
  15. Gass JD, Blodi BA (1993) Idiopathic juxtafoveolar retinal telangiectasis. Update of classification and follow-up study. Ophthalmology 100:1536–154CrossRefPubMedGoogle Scholar
  16. Gaudric A, Ducos de Lahitte G, Cohen SY, Massin P, Haouchine B (2006) Optical coherence tomography in group 2A idiopathic juxtafoveolar retinal telangiectasis. Arch Ophthalmol 124:1410–1419. doi: 10.1001/archopht.124.10.1410 CrossRefPubMedGoogle Scholar
  17. Gillies MC, Zhu M, Chew E, Barthelmes D, Hughes E, Ali H, Holz FG, Scholl HPN, Charbel Issa P (2009) Familial asymptomatic macular telangiectasia type 2. Ophthalmology 116:2422–2429. doi: 10.1016/j.ophtha.2009.05.010 CrossRefPubMedPubMedCentralGoogle Scholar
  18. Helb H-M, Charbel Issa P, van der Veen RLP, Berendschot TTJM, Scholl HPN, Holz FG (2008) Abnormal macular pigment distribution in type 2 idiopathic macular telangiectasia. Retina 28:808–816. doi: 10.1097/IAE.0b013e31816d81aa CrossRefPubMedGoogle Scholar
  19. Heeren TFC, Clemons T, Scholl HPN, Bird AC, Holz FG, Charbel Issa P (2015) Progression of vision loss in macular telangiectasia type 2. Invest Ophthalmol Vis Sci 56:3905–3912. doi: 10.1167/iovs.15-16915 CrossRefPubMedGoogle Scholar
  20. Koizumi H, Iida T, Maruko I (2006) Morphologic features of group 2A idiopathic juxtafoveolar retinal telangiectasis in three-dimensional optical coherence tomography. Am J Ophthalmol 142:340–343. doi: 10.1016/j.ajo.2006.03.021 CrossRefPubMedGoogle Scholar
  21. Krivosic V, Tadayoni R, Massin P, Erginay A, Gaudric A (2009) Spectral domain optical coherence tomography in type 2 idiopathic perifoveal telangiectasia. Ophthalmic Surg Lasers Imaging 40:379–384CrossRefPubMedGoogle Scholar
  22. Nunes RP, Goldhardt R, de Amorim Garcia Filho CA, Thorell MR, Abbey AM, Kuriyan AE, Modi YS, Shah M, Yehoshua Z, Gregori G, Feuer W, Rosenfeld PJ (2015) Spectral-domain optical coherence tomography measurements of choroidal thickness and outer retinal disruption in macular telangiectasia type 2. Ophthalmic Surg Lasers Imaging Retina 46:162–170. doi: 10.3928/23258160-20150213-17 CrossRefPubMedGoogle Scholar
  23. Sallo FB, Peto T, Egan C, Wolf-Schnurrbusch UEK, Clemons TE, Gillies MC, Pauleikhoff D, Rubin GS, Chew EY, Bird AC (2012a) The IS/OS junction layer in the natural history of type 2 idiopathic macular telangiectasia. Invest Ophthalmol Vis Sci 53:7889–7895. doi: 10.1167/iovs.12-10765 CrossRefPubMedPubMedCentralGoogle Scholar
  24. Sallo FB, Peto T, Egan C, Wolf-Schnurrbusch UEK, Clemons TE, Gillies MC, Pauleikhoff D, Rubin GS, Chew EY, Bird AC (2012b) “En face” OCT imaging of the IS/OS junction line in type 2 idiopathic macular telangiectasia. Invest Ophthalmol Vis Sci 53:6145–6152. doi: 10.1167/iovs.12-10580 CrossRefPubMedPubMedCentralGoogle Scholar
  25. Spaide RF, Klancnik JM, Cooney MJ (2015) Retinal vascular layers in macular telangiectasia type 2 imaged by optical coherence tomographic angiography. JAMA Ophthalmol 133:66–73. doi: 10.1001/jamaophthalmol.2014.3950 CrossRefPubMedGoogle Scholar
  26. Thorell MR, Zhang Q, Huang Y, An L, Durbin MK, Laron M, Sharma U, Stetson PF, Gregori G, Wang RK, Rosenfeld PJ (2014) Swept-source OCT angiography of macular telangiectasia type 2. Ophthalmic Surg Lasers Imaging Retina 45:369–380. doi: 10.3928/23258160-20140909-06 CrossRefPubMedGoogle Scholar
  27. Wang Q, Tuten WS, Lujan BJ, Holland J, Bernstein PS, Schwartz SD, Duncan JL, Roorda A (2015) Adaptive optics microperimetry and OCT images show preserved function and recovery of cone visibility in macular telangiectasia type 2 retinal lesions. Invest Ophthalmol Vis Sci 56:778–786. doi: 10.1167/iovs.14-15576 CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer India 2017

Authors and Affiliations

  • Peter Charbel Issa
    • 1
  • Simone Müller
    • 1
  • Tjebo F. C. Heeren
    • 1
  • Frank G. Holz
    • 1
  1. 1.Department of OphthalmologyUniversity of BonnBonnGermany

Personalised recommendations